Van Welden, Sophie
Selfridge, Andrew C.
Hindryckx, Pieter
Article History
First Online: 30 August 2017
Competing interests
: P.H. has received consultancy fees from Abbvie, Ferring and Takeda, honoraria for speaking from Abbvie, Chiesi, Falk Pharma, Ferring, Takeda and Vifor Pharma, and an investigator-initiated study grant from Takeda. S.V.W. and A.S. declare no competing interests.